Open original FDA record ↗Recall record
- FDA identifier
- Z-0718-2024
- Company in FDA record
- Olympus Corporation of the Americas
- FDA classification date
- Jan 12, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Affected products may potentially have a breached sterile pouch seal. A breached sterile pouch seal may lead to minor procedure delays (if noticed prior to use) or patient infections (if not noticed prior to use in patient).
Source facts
- Action
- On December 4, 2023, the firm notified affected customers via Urgent Medical Device Removal letters. Customers were instructed to identify and quarantine the affected model/lot. Affected product should not be used. Olympus will issue a credit to customers upon the return of the affected product. If product was distributed outside the customer's facility, the customer should notify those outside facilities immediately. If you require additional information, please contact the company by phone at (647) 999-3203 or by e-mail at Cynthia.Ow@olympus.com.
- Initiated
- 2023-12-04
- Root cause
- Under Investigation by firm
- Distribution
- Domestic distribution to the following states: AK AR AZ CA FL GA IA ID IN KS KY LA MA MI NC ND NE NJ NY OR PA SC SD TN TX VA WI International distribution to Canada, Latin America, and Europe.
- Recall number
- Z-0718-2024
- Recall status
- Open, Classified
- CDRH record ID
- 204989
- FDA classified
- 2024-01-12
- Recall event number
- 93629